Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
Previous studies have suggested that, different types of unmyelinated bladder afferent C-fibres, such as capsaicin-sensitive and capsaicin-resistant mediate the voiding reflex in overactive bladder (OAB). Considering its polymodal features, we explored the urodynamic effect of primary afferent neurons modulation on detrusor activity in normal and OAB rats. Experiments were performed on 48 female rats. OAB was induced by intraperitoneal administration of cyclophosphamide. All the surgical procedures and urodynamic studies were performed under urethane anaesthesia. Cystometry was done after a 1 h recovery period from the surgical procedure. All animals were randomly divided into six groups: control, chronic OAB, chronic OAB after capsaicin or lidocaine instillation, control capsaicin or lidocaine instillation. The measurements represent the average of five bladder micturition cycles. We analyzed: basal, threshold, micturition voiding pressure; intercontraction interval; compliance; functional bladder capacity; motility index; detrusor overactivity index. We used chronic cyclophosphamide OAB model for further investigations. In healthy rats, intravesical instillation of capsaicin caused complete inhibition of detrusor contractility preventing from proper voiding function of the bladder. Contrary, lidocaine has no influence on micturition cycles in intact animals. Also, intravesical instillation of capsaicin and lidocaine reduced the severity of detrusor overactivity of OAB rats leading to improvement of cystometric parameters.
Juszczak
K
K
Department of Pathophysiology, Jagiellonian University, Medical College, Cracow, Poland. kajus13@poczta.onet.pl
Ziomber
A
A
Wyczolkowski
M
M
Thor
P J
PJ
D000283:Administration, Intravesical; D000344:Afferent Pathways / Q000187:drug effects*; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D002211:Capsaicin / Q000008:administration & dosage / Q000494:pharmacology; D003556:Cystitis / Q000139:chemically induced / Q000503:physiopathology; D004195:Disease Models, Animal; D005260:Female; D008012:Lidocaine / Q000008:administration & dosage / Q000494:pharmacology; D036421:Nerve Fibers, Unmyelinated / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D018689:Sensory System Agents / Q000008:administration & dosage / Q000494:pharmacology; D001743:Urinary Bladder / Q000294:innervation* / Q000503:physiopathology; D053201:Urinary Bladder, Overactive / Q000139:chemically induced / Q000503:physiopathology*; D014554:Urination; D014563:Urodynamics / Q000187:drug effects*
D000779:Anesthetics, Local; D018689:Sensory System Agents; D008012:Lidocaine; D002211:Capsaicin